|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
BCYC | Keen Nicholas | CHIEF SCIENTIFIC OFFICER | Apr 03 | Sale | 23.81 | 790 | 18,810 | 62,803 | Apr 05 04:30 PM |
BCYC | Keen Nicholas | Chief Scientific Officer | Jan 03 | Sale | 17.50 | 2,640 | 46,200 | 63,593 | Jan 04 06:34 PM |
BCYC | Keen Nicholas | Chief Scientific Officer | Oct 03 | Sale | 20.00 | 272 | 5,440 | 38,233 | Oct 05 05:49 PM |
BCYC | Keen Nicholas | Chief Scientific Officer | Jul 03 | Sale | 25.10 | 336 | 8,434 | 38,505 | Jul 06 04:50 PM |
BCYC | Keen Nicholas | Chief Scientific Officer | Apr 03 | Sale | 21.11 | 319 | 6,734 | 38,841 | Apr 05 04:43 PM |
BCYC | Keen Nicholas | Chief Scientific Officer | Jan 03 | Sale | 29.06 | 1,817 | 52,802 | 39,160 | Jan 05 09:14 PM |
BCYC | Keen Nicholas | Chief Scientific Officer | Dec 21 | Option Exercise | 14.00 | 15,477 | 216,678 | 15,477 | Dec 22 09:01 PM |
BCYC | Keen Nicholas | Chief Scientific Officer | Oct 01 | Sale | 45.00 | 1,188 | 53,460 | 2,178 | Oct 05 04:16 PM |
BCYC | Keen Nicholas | Chief Scientific Officer | Oct 05 | Sale | 45.10 | 2,178 | 98,228 | 0 | Oct 05 04:16 PM |
BCYC | Keen Nicholas | Chief Scientific Officer | Sep 15 | Sale | 45.00 | 3,000 | 135,000 | 5,321 | Sep 17 04:47 PM |
BCYC | Keen Nicholas | Chief Scientific Officer | Sep 16 | Sale | 45.01 | 1,955 | 87,995 | 3,366 | Sep 17 04:47 PM |
BCYC | Keen Nicholas | Chief Scientific Officer | Sep 02 | Sale | 40.00 | 10,000 | 400,000 | 8,321 | Sep 03 04:47 PM |
BCYC | Keen Nicholas | Chief Scientific Officer | Jul 14 | Sale | 35.00 | 10,000 | 350,000 | 18,321 | Jul 16 06:27 PM |
BCYC | Keen Nicholas | Chief Scientific Officer | Mar 31 | Sale | 30.00 | 10,000 | 300,000 | 28,321 | Apr 02 04:45 PM |
BCYC | Keen Nicholas | Chief Scientific Officer | Mar 12 | Sale | 28.50 | 9,783 | 278,767 | 38,538 | Mar 16 07:41 PM |
BCYC | Keen Nicholas | Chief Scientific Officer | Mar 15 | Sale | 28.00 | 217 | 6,076 | 38,321 | Mar 16 07:41 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite